Show items per page
Elements: 35
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Implementation of raltegravir in routine clinical practice: selection criteria for choosing this drug, virologic response rates, and characteristics of failures Scherrer, A. U.; von Wyl, Viktor; Fux, C. A.; Opravil, Milos; ... Gunthard, Huldrych 2010
add to browser selection
Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007 Ballif, Marie; Ledergerber, Bruno; Battegay, Manuel; Cavassini, Matthias; ... Weber, Rainer 2009
add to browser selection
Safety and efficacy of once-daily nevirapine dosing: a multicohort study Calmy, Alexandra; Vallier, Nathalie; Nguyen, Alain; Lange, J. M.; ... Wit, F. W. 2009
add to browser selection
Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study Conen, Anna; Fehr, Jan; Glass, T. R.; Furrer, Hansjakob; ... Battegay, Manuel 2009
add to browser selection
Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV Young, Jim; Bucher, H. C.; Guenthard, H. F.; Rickenbach, Martin; ... Battegay, Manuel 2009
add to browser selection
Is it smart to continue to study treatment interruptions? Hirschel, Bernard; Flanigan, Timothy 2009
add to browser selection
Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study Fux, C. A.; Rauch, Andri; Simcock, Mathew; Bucher, H. C.; ... Furrer, Hansjakob 2008
add to browser selection
VIH – sida Traitement de l'infection à VIH en 2006 : points forts Schiffer, V.; Hirschel, Bernard 2007
add to browser selection
Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission Elzi, Luigia; Schlegel, Matthias; Weber, Rainer; Hirschel, Bernard; ... Furrer, Hansjakob 2007
add to browser selection
Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study Fux, C. A.; Simcock, Mathew; Wolbers, Marcel; Bucher, H. C.; ... Furrer, Hansjakob 2007
add to browser selection
No patient left behind--better treatments for resistant HIV infection Hirschel, Bernard; Perneger, Thomas 2007
add to browser selection
Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study Glass, T. R.; De Geest, Sabina; Weber, Rainer; Vernazza, P. L.; ... Bucher, H. C. 2006
add to browser selection
Sida Molécules récentes, stratégies thérapeutiques d'avenir et nouvelles cibles du traitement Delessert, K.; Schiffer, V.; Hirschel, Bernard 2005
add to browser selection
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy Kaufmann, G. R.; Furrer, Hansjakob; Ledergerber, Bruno; Perrin, Luc; ... Battegay, Manuel 2005
add to browser selection
Highly active antiretroviral therapy (HAART) retreatment in patients on CD4-guided therapy achieved similar virologic suppression compared with patients on continuous HAART: the HIV Netherlands Australia Thailand Research Collaboration 001.4 study Ananworanich, Jintanat; Siangphoe, Umaporn; Hill, Andrew; Cardiello, Peter; ... Ruxrungtham, Kiat 2005
add to browser selection
Saquinavir trough concentration before and after switching NRTI to tenofovir in patients treated with once-daily saquinavir hard gel capsule/ritonavir 1600 mg/100 mg Ananworanich, Jintanat; Siangphoe, Umaporn; Mahanontharit, Apicha; Hill, Andrew; ... Ruxrungtham, Kiat 2004
add to browser selection
Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naive adults with advanced HIV infection Hirsch, M. S.; Steigbigel, R. T.; Staszewski, Scholomo; McMahon, Deborah; ... Leavitt, R. Y. 2003
add to browser selection
Beware of drug holidays before HIV salvage therapy Hirschel, Bernard 2003
add to browser selection
Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study Bernasconi, Enos; Boubaker, Karim; Junghans, Cornelia; Flepp, Markus; ... Telenti, Amalio 2002
add to browser selection
Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort Study Bucher, H. C.; Bichsel, M.; Taffe, Patrick; Furrer, Hansjakob; ... Battegay, M. 2002
add to browser selection
Modern anti-HIV therapy Flepp, Markus; Schiffer, V.; Weber, R.; Hirschel, Bernard 2001
add to browser selection
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort Study Friedl, A. C.; Ledergerber, Bruno; Flepp, Markus; Hirschel, Bernard; ... Weber, R. 2001
add to browser selection
Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patients Battegay, M.; Vernazza, P. L.; Bernasconi, Enos; Flepp, Markus; ... Hirschel, Bernard 2001
add to browser selection
Antiretroviral prophylaxis for community exposure to the human immunodeficiency virus in Switzerland, 1997-2000 Bernasconi, Enos; Jost, J.; Ledergerber, Bruno; Hirschel, Bernard; ... Sudre, Philippe 2001
add to browser selection
Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study Rutschmann, Olivier Thierry; Vernazza, P. L.; Bucher, H. C.; Opravil, M.; ... Hirschel, Bernard 2000
add to browser selection
Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial. The M/3331/0013B Study Group Joly, V.; Moroni, M.; Concia, Ercole; Lazzarin, A.; ... de Cian, W. 2000
add to browser selection
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study Furrer, Hansjakob; Egger, M.; Opravil, M.; Bernasconi, Enos; ... Malinverni, R. 1999
add to browser selection
Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapy. Swiss HIV Cohort Study Zinkernagel, C.; Ledergerber, Bruno; Battegay, M.; Cone, R. W.; ... Opravil, M. 1999
add to browser selection
Progress and problems in the fight against AIDS Hirschel, Bernard; Francioli, P. 1998
add to browser selection
Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study Rutschmann, Olivier Thierry; Opravil, M.; Iten, A.; Malinverni, R.; ... Hirschel, Bernard 1998
add to browser selection
A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort Study Rutschmann, Olivier Thierry; Opravil, M.; Iten, A.; Malinverni, R.; ... Hirschel, Bernard 1998
add to browser selection
Adding saquinavir to stavudine in patients with advanced HIV-1 infection Rutschmann, Olivier Thierry; Kaiser, Laurent; Perrin, Luc; Fathi, Marc; Hirschel, Bernard 1997
add to browser selection
Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study Egger, M.; Hirschel, Bernard; Francioli, Patrick; Sudre, Philippe; ... Battegay, M. 1997
add to browser selection
Combination therapy in primary HIV infection Perrin, Luc; Hirschel, Bernard 1996
add to browser selection
Antivirale Substanzen: Gegen was? Fur wen? Hirschel, Bernard 1990